The Week's Top Stories: Breakthrough COVID, FDA Approvals, and More

Article

This week's most-read stories discussed unforeseen consequences of the COVID-19 pandemic, including an increase in gastrointestinal diseases and a decrease in childhood asthma diagnoses.

Recent Videos
Related Content
The Latest in Clostridioides difficile Research and News

The Latest in Clostridioides difficile Research and News

Contagion Editorial Team
November 21st 2024
Article
Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting

Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting

George Sakoulas, MD
November 6th 2023
Podcast
Human Avian Flu Update: Possible Case With Undetermined Source of Infection

Human Avian Flu Update: Possible Case With Undetermined Source of Infection

Sophia Abene
November 20th 2024
Article
C difficile, Antimicrobials, and the Patients Most Affected

C difficile, Antimicrobials, and the Patients Most Affected

Nina Cosdon
November 23rd 2022
Podcast
COVID and Influenza Vaccinations Well Tolerated Whether Given Simultaneously or Sequentially

COVID and Influenza Vaccinations Well Tolerated Whether Given Simultaneously or Sequentially

Kenneth Bender, PharmD, MA
November 19th 2024
Article
Oral Vancomycin Reduces CDI by 64% in Stem Cell Transplant Patients

Oral Vancomycin Reduces CDI by 64% in Stem Cell Transplant Patients

Sophia Abene
November 19th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.